This announcement is a separate document:
ステラファーマ：ステラファーマ、三菱ケミカルグループ、東京大学が共同研究契約締結～ホウ素中性子捕捉療法（BNCT）用ポリビニルアルコール（PVA）製剤の実用化を加速～
Stella Pharma: Stellar Pharma, Mitsubishi Chemical Group, and the University of Tokyo sign a joint research agreement - Accelerating the practical application of polyvinyl alcohol (PVA) formulations for boron neutron capture therapy (BNCT)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.